FDAnews
www.fdanews.com/articles/133982-ocular-therapeutix-grabs-14-million-in-new-round-for-eye-therapies

Ocular Therapeutix Grabs $14 Million in New Round for Eye Therapies

February 3, 2011
Ocular Therapeutix has found a new investor and a fresh round of capital to advance its hydrogel-based treatments for the eye, CEO Amar Sawhney said.
Xconomy